Leptin receptor somatic mutations are frequent in HCV-infected cirrhotic liver and associated with hepatocellular carcinoma

Gastroenterology

Volumn 146, Issue 1, 2014, Pages

  Ikeda, Atsuyuki ^a   Shimizu, Takahiro ^a   Matsumoto, Yuko ^a   Fujii, Yosuke ^a   Eso, Yuji ^a   Inuzuka, Tadashi ^a   Mizuguchi, Aya ^a   Shimizu, Kazuharu ^a   Hatano, Etsuro ^a   Uemoto, Shinji ^a   Chiba, Tsutomu ^a   Marusawa, Hiroyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Genetics; Liver Cancer; STAT3; Whole Exome Sequencing

Indexed keywords

LEPTIN RECEPTOR; STAT3 PROTEIN; THIOACETAMIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CASE REPORT; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXOME; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; HEPATITIS C; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOMATIC MUTATION;

EID: 84890761844     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.09.025     Document Type: Article

References (51)

1. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
2. T. Chiba, H. Marusawa, and T. Ushijima Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation Gastroenterology 143 2012 550 563
3. C. Lengauer, K.W. Kinzler, and B. Vogelstein Genetic instabilities in human cancers Nature 396 1998 643 649
4. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
5. S.P. Hussain, J. Schwank, and F. Staib TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer Oncogene 26 2007 2166 2176
6. L.A. Loeb, J.H. Bielas, and R.A. Beckman Cancers exhibit a mutator phenotype: clinical implications Cancer Res 68 2008 3551 3557
7. M.T. Barrett, C.A. Sanchez, and L.J. Prevo Evolution of neoplastic cell lineages in Barrett oesophagus Nat Genet 22 1999 106 109
8. S.J. Leedham, T.A. Graham, and D. Oukrif Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia Gastroenterology 136 2009 542 550
9. S.P. Hussain, L.J. Hofseth, and C.C. Harris Radical causes of cancer Nat Rev Cancer 3 2003 276 285
10. Y. Matsumoto, H. Marusawa, and K. Kinoshita Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium Nat Med 13 2007 470 476
11. J. Komori, H. Marusawa, and T. Machimoto Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma Hepatology 47 2008 888 896
12. Y. Endo, H. Marusawa, and T. Kou Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers Gastroenterology 135 2008 889 898
13. K. Ikeda, H. Marusawa, and Y. Osaki Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study Ann Intern Med 146 2007 649 656
14. Y. Endo, H. Marusawa, and K. Kinoshita Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling Oncogene 26 2007 5587 5595
15. T. Kou, H. Marusawa, and K. Kinoshita Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis Int J Cancer 120 2007 469 476
16. X. Wei, V. Walia, and J.C. Lin Exome sequencing identifies GRIN2A as frequently mutated in melanoma Nat Genet 43 2011 442 446
17. L. Wang, S. Tsutsumi, and T. Kawaguchi Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiency Genome Res 22 2012 208 219
18. K. Wang, J. Kan, and S.T. Yuen Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer Nat Genet 43 2011 1219 1223
19. A. Fujimoto, Y. Totoki, and T. Abe Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators Nat Genet 44 2012 760 764
20. C. Guichard, G. Amaddeo, and S. Imbeaud Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma Nat Genet 44 2012 694 698
21. A. Nasu, H. Marusawa, and Y. Ueda Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing PLoS One 6 2011 e24907
22. N. Nishijima, H. Marusawa, and Y. Ueda Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing PLoS One 7 2012 e35052
23. I. Varela, P. Tarpey, and K. Raine Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 2011 539 542
24. K. Clément, C. Vaisse, and N. Lahlou A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction Nature 392 1998 398 401
25. P. Laurent-Puig, and J. Zucman-Rossi Genetics of hepatocellular tumors Oncogene 25 2006 3778 3786
26. S. Morita, Y. Matsumoto, and S. Okuyama Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma Carcinogenesis 32 2011 1706 1712
27. G.H. Lee, R. Proenca, and J.M. Montez Abnormal splicing of the leptin receptor in diabetic mice Nature 379 1996 632 635
28. F.F. Becker Thioacetamide hepatocarcinogenesis J Natl Cancer Inst 71 1983 553 558
29. J. Schnur, P. Nagy, and A. Sebestyén Chemical hepatocarcinogenesis in transgenic mice overexpressing mature TGF beta-1 in liver Eur J Cancer 35 1999 1842 1845
30. C. Greenman, P. Stephens, and R. Smith Patterns of somatic mutation in human cancer genomes Nature 446 2007 153 158
31. X.J. Yan, J. Xu, and Z.H. Gu Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia Nat Genet 43 2011 309 315
32. M.W. Schwartz, S.C. Woods, and D. Porte Central nervous system control of food intake Nature 404 2000 661 671
33. L.A. Tartaglia The leptin receptor J Biol Chem 272 1997 6093 6096
34. F. Peelman, H. Iserentant, and A.S. De Smet Mapping of binding site III in the leptin receptor and modeling of a hexameric leptin.leptin receptor complex J Biol Chem 281 2006 15496 15504
35. I.S. Farooqi, T. Wangensteen, and S. Collins Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor N Engl J Med 356 2007 237 247
36. W. Kimber, F. Peelman, and X. Prieur Functional characterization of naturally occurring pathogenic mutations in the human leptin receptor Endocrinology 149 2008 6043 6052
37. S. Yang, H.Z. Lin, and J. Hwang Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 61 2001 5016 5023
38. J.A. Marrero, R.J. Fontana, and G.L. Su NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 36 2002 1349 1354
39. Y. Kodama, and D.A. Brenner c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: multiple roles in multiple steps Hepatology 49 2009 6 8
40. L.F. Hourigan, G.A. Macdonald, and D. Purdie Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis Hepatology 29 1999 1215 1219
41. A. Lonardo, L.E. Adinolfi, and P. Loria Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease Gastroenterology 126 2004 586 597
42. K. Ohata, K. Hamasaki, and K. Toriyama Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection Cancer 97 2003 3036 3043
43. B. Cohen, D. Novick, and M. Rubinstein Modulation of insulin activities by leptin Science 274 1996 1185 1188
44. Y. Wang, K.K. Kuropatwinski, and D.W. White Leptin receptor action in hepatic cells J Biol Chem 272 1997 16216 16223
45. E. Elinav, A. Abd-Elnabi, and O. Pappo Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation J Hepatol 44 2006 529 536
46. K. Wang, J. Kan, and S.T. Yuen Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer Nat Genet 43 2011 1219 1223
47. I. Varela, P. Tarpey, and K. Raine Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma Nature 469 2011 539 542
48. X.J. Yan, J. Xu, and Z.H. Gu Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia Nat Genet 43 2011 309 315
49. Y. Endo, H. Marusawa, and K. Kinoshita Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling Oncogene 26 2007 5587 5595
50. S. Morita, Y. Matsumoto, and S. Okuyama Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma Carcinogenesis 32 2011 1706 1712
51. H.H. Aly, K. Watashi, and M. Hijikata Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes J Hepatol 46 2007 26 36